Cullinan Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.98M | Sell |
25,516
-5,627
| -18% | -$2.01M | 0.73% | 38 |
|
|
2025
Q4 | $10.2M | Sell |
31,143
-301
| -1% | -$95.5K | 0.69% | 38 |
|
|
2025
Q3 | $8.87M | Sell |
31,444
-2,602
| -8% | -$755K | 0.58% | 45 |
|
|
2025
Q2 | $9.51M | Sell |
34,046
-477
| -1% | -$135K | 0.63% | 40 |
|
|
2025
Q1 | $10.8M | Sell |
34,523
-1,511
| -4% | -$446K | 0.76% | 34 |
|
|
2024
Q4 | $9.39M | Sell |
36,034
-11,869
| -25% | -$3.52M | 0.6% | 41 |
|
|
2024
Q3 | $15.2M | Sell |
47,903
-3,111
| -6% | -$1.02M | 0.86% | 31 |
|
|
2024
Q2 | $15.9M | Sell |
51,014
-123,606
| -71% | -$36.3M | 0.9% | 29 |
|
|
2024
Q1 | $49.6M | Buy |
174,620
+18,733
| +12% | +$5.48M | 2.78% | 7 |
|
|
2023
Q4 | $44.9M | Sell |
155,887
-10,968
| -7% | -$2.99M | 2.5% | 8 |
|
|
2023
Q3 | $44.8M | Sell |
166,855
-43,567
| -21% | -$10.9M | 2.61% | 8 |
|
|
2023
Q2 | $46.7M | Sell |
210,422
-1,515
| -0.7% | -$352K | 2.57% | 7 |
|
|
2023
Q1 | $51.2M | Buy |
211,937
+9,173
| +5% | +$2.25M | 2.99% | 5 |
|
|
2022
Q4 | $53.3M | Sell |
202,764
-517
| -0.3% | -$139K | 2.95% | 6 |
|
|
2022
Q3 | $45.8M | Buy |
203,281
+732
| +0.4% | +$177K | 2.89% | 5 |
|
|
2022
Q2 | $49.3M | Buy |
202,549
+3,431
| +2% | +$841K | 3.01% | 5 |
|
|
2022
Q1 | $48.2M | Buy |
199,118
+1,617
| +0.8% | +$372K | 2.53% | 6 |
|
|
2021
Q4 | $44.4M | Buy |
197,501
+4,345
| +2% | +$917K | 2.26% | 7 |
|
|
2021
Q3 | $41.1M | Buy |
193,156
+21,128
| +12% | +$4.86M | 2.27% | 7 |
|
|
2021
Q2 | $41.9M | Buy |
172,028
+11,171
| +7% | +$2.75M | 2.35% | 6 |
|
|
2021
Q1 | $40M | Sell |
160,857
-4,708
| -3% | -$1.12M | 2.3% | 6 |
|
|
2020
Q4 | $38.1M | Sell |
165,565
-4,100
| -2% | -$945K | 2.28% | 6 |
|
|
2020
Q3 | $43.1M | Sell |
169,665
-2,750
| -2% | -$681K | 2.78% | 4 |
|
|
2020
Q2 | $40.7M | Buy |
172,415
+125,988
| +271% | +$28.7M | 2.85% | 5 |
|
|
2020
Q1 | $9.41M | Sell |
46,427
-3,830
| -8% | -$837K | 0.77% | 27 |
|
|
2019
Q4 | $12.1M | Buy |
50,257
+641
| +1% | +$141K | 0.81% | 26 |
|
|
2019
Q3 | $9.6M | Sell |
49,616
-1,960
| -4% | -$376K | 0.68% | 39 |
|
|
2019
Q2 | $9.5M | Buy |
51,576
+671
| +1% | +$120K | 0.69% | 37 |
|
|
2019
Q1 | $9.67M | Sell |
50,905
-1,280
| -2% | -$244K | 0.73% | 36 |
|
|
2018
Q4 | $10.2M | Sell |
52,185
-433
| -0.8% | -$84.5K | 0.84% | 25 |
|
|
2018
Q3 | $10.9M | Sell |
52,618
-8,007
| -13% | -$1.58M | 0.79% | 27 |
|
|
2018
Q2 | $11.2M | Sell |
60,625
-35,281
| -37% | -$6.24M | 0.86% | 23 |
|
|
2018
Q1 | $16.4M | Sell |
95,906
-820
| -0.8% | -$151K | 1.24% | 10 |
|
|
2017
Q4 | $16.8M | Sell |
96,726
-1,026
| -1% | -$182K | 1.24% | 11 |
|
|
2017
Q3 | $18.2M | Buy |
97,752
+8,215
| +9% | +$1.46M | 1.4% | 9 |
|
|
2017
Q2 | $15.4M | Buy |
89,537
+8,348
| +10% | +$1.36M | 1.2% | 12 |
|
|
2017
Q1 | $13.3M | Buy |
81,189
+12,960
| +19% | +$2.15M | 1.09% | 15 |
|
|
2016
Q4 | $9.98M | Sell |
68,229
-1,376
| -2% | -$207K | 0.85% | 27 |
|
|
2016
Q3 | $11.6M | Sell |
69,605
-1,795
| -3% | -$304K | 0.99% | 17 |
|
|
2016
Q2 | $10.9M | Buy |
71,400
+10,680
| +18% | +$1.66M | 0.88% | 21 |
|
|
2016
Q1 | $9.1M | Buy |
60,720
+6,450
| +12% | +$958K | 0.78% | 30 |
|
|
2015
Q4 | $8.81M | Buy |
54,270
+13,129
| +32% | +$2.06M | 0.77% | 37 |
|
|
2015
Q3 | $5.69M | Buy |
41,141
+771
| +2% | +$122K | 0.52% | 50 |
|
|
2015
Q2 | $6.2M | Buy |
40,370
+1,250
| +3% | +$200K | 0.51% | 47 |
|
|
2015
Q1 | $6.25M | Buy |
39,120
+4,200
| +12% | +$661K | 0.49% | 46 |
|
|
2014
Q4 | $5.56M | Buy |
34,920
+8,810
| +34% | +$1.37M | 0.59% | 31 |
|
|
2014
Q3 | $3.67M | Buy |
+26,110
| New | +$3.41M | 0.42% | 39 |
|
|
2014
Q2 | – | Sell |
-17,010
| Closed | -$2.1M | – | 84 |
|
|
2014
Q1 | $2.1M | Buy |
17,010
+5,690
| +50% | +$690K | 0.24% | 55 |
|
|
2013
Q4 | $1.29M | Buy |
11,320
+770
| +7% | +$87.6K | 0.15% | 64 |
|
|
2013
Q3 | $1.18M | Sell |
10,550
-3,850
| -27% | -$417K | 0.16% | 67 |
|
|
2013
Q2 | $1.42M | Buy |
+14,400
| New | +$1.49M | 0.19% | 64 |
|
Other funds holding AMGN
VCM
VPM
Cullinan Associates's AMGN Position: Q1 2026 in Review
Cullinan Associates reduced its Amgen (AMGN) stake by 18% in Q1 2026, selling an estimated $2.01M and leaving 25,516 shares worth $8.98M. The position accounts for 0.73% of the portfolio, ranked #38.
Cullinan Associates first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $53.3M in Q4 2022. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Cullinan Associates held 25,516 shares of Amgen worth $8.98M as of Q1 2026.
- Cullinan Associates sold 5,627 Amgen shares in Q1 2026, an estimated $2.01M.
- Amgen made up 0.73% of Cullinan Associates's portfolio in Q1 2026, its #38 holding.
- Cullinan Associates first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
- Cullinan Associates's Amgen position peaked at $53.3M in Q4 2022.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.